"Should additional phase 2 and phase 3 clinical trials support repurposing one or more GLP-1 receptor agonists for AUD, these treatments could have broad clinical infiltration, with potential to bypass many traditional impediments to the uptake of AUD medications, including low public and provider awareness and stigma toward AUD treatments," the authors write
The supplements to take with tirzepatide guide covers the most important additions for users at the maximum dose
This gradual rate is intentional: it protects muscle mass, reduces side effects, and produces durable results
All analyses were performed for the intention-to-treat population, defined as patients who underwent randomization, regardless of treatment received
Table 1 Drug therapy in the comorbidities of diabetes and pancreatic cancer
This dual-agonist approach is what sets tirzepatide apart, as it may offer enhanced effects on body weight loss and metabolic control